These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 24928266)

  • 21. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
    Womble PR; Linsell SM; Gao Y; Ye Z; Montie JE; Gandhi TN; Lane BR; Burks FN; Miller DC;
    J Urol; 2015 Aug; 194(2):403-9. PubMed ID: 25896556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
    Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
    Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
    J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative.
    Womble PR; Dixon MW; Linsell SM; Ye Z; Montie JE; Lane BR; Miller DC; Burks FN;
    J Urol; 2014 Jun; 191(6):1787-92. PubMed ID: 24345442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy.
    Liss MA; Peeples AN; Peterson EM
    J Clin Microbiol; 2011 Mar; 49(3):1116-8. PubMed ID: 21177893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis.
    Cohen JE; Landis P; Trock BJ; Patel HD; Ball MW; Auwaerter PG; Schaeffer E; Carter HB
    J Urol; 2015 Feb; 193(2):552-6. PubMed ID: 25111911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
    Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
    J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
    Jiang P; Liss MA; Szabo RJ
    J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate?
    Liss MA; Nakamura KK; Meuleners R; Kolla SB; Dash A; Peterson EM
    Urology; 2013 Jul; 82(1):67-71. PubMed ID: 23806391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.